clinical trials for patients with Alport syndrome
Feb 11, 2026
Breakthroughs in Alport Syndrome Treatment: A New Era of Hope
Alport syndrome, an inherited disease, predominantly manifests in its X-linked form, constituting around 80% of cases. Without intervention, roughly 90% of affected males face kidney failure by age 40, whereas females typically experience a slower progression to this condition. Many Alport syndrome cases go unnotic...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
